These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2068474)

  • 41. Aztreonam: the first monobactam.
    Neu HC
    Med Clin North Am; 1988 May; 72(3):555-66. PubMed ID: 3280906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection. Comparative cost-effectiveness.
    Moore RD; Smith CR; Holloway JJ; Lietman PS
    Arch Intern Med; 1986 Jun; 146(6):1153-7. PubMed ID: 3087307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical studies with a mezlocillin-oxacillin combination in a children's intensive care ward].
    Schöch G
    Arzneimittelforschung; 1979; 29(12a):2017-20. PubMed ID: 543916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ceftriaxone versus aztreonam plus cefazolin for infections in cancer patients with adequate neutrophil counts.
    Menichetti F; Del Favero A; Bucaneve G; Minotti V; Patoia L; Pauluzzi S
    Infection; 1990; 18(3):166-9. PubMed ID: 2365468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multicenter trial of prophylaxis with clindamycin plus aztreonam or cefotaxime in gynecologic surgery.
    Mangioni C; Bianchi L; Bolis PF; Lomeo AM; Mazzeo F; Ventriglia L; Scalambrino S
    Rev Infect Dis; 1991; 13 Suppl 7():S621-5. PubMed ID: 2068470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aztreonam in treatment of intra-abdominal infections.
    Malangoni MA
    Urology; 1988 Jun; 31(6 Suppl):28-32. PubMed ID: 3287747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of aztreonam in serious gram-negative infections.
    Smith G; Bunney RG; Farrell ID; Wood MJ
    J Antimicrob Chemother; 1988 Feb; 21(2):233-41. PubMed ID: 3283094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli.
    Clergeot A; Steru D; Rosset MA; Carbon C
    Rev Infect Dis; 1991; 13 Suppl 7():S648-51. PubMed ID: 2068476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized comparison of aztreonam and cefuroxime in gram-negative upper urinary tract infections.
    Friman G; Cars O; Bäck E; Beckman H; Carlsson M; Forssell J; Fredlund H; Neringer R; Odenholt-Tornqvist I; Rydén C
    Infection; 1989; 17(5):284-9. PubMed ID: 2689345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of aztreonam/metronidazole and cefotaxime/metronidazole in elective colorectal surgery: antimicrobial prophylaxis must include gram-positive cover.
    Morris DL; Wilson SR; Pain J; Edwardson KF; Jones J; Strachan C; Slack R
    J Antimicrob Chemother; 1990 Apr; 25(4):673-8. PubMed ID: 2190974
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of aztreonam in the treatment of severe bacterial infections.
    Romero-Vivas J; Rodríguez-Créixems M; Bouza E; Hellín T; Guerrero A; Martínez-Beltrán J; García de la Torre M
    Antimicrob Agents Chemother; 1985 Aug; 28(2):222-6. PubMed ID: 3834832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study.
    Dupont H; Marciniak S; Zogheib E; Mammeri H; Friggeri A; Ammenouche N; Levrard M; Airapetian N; Tinturier F; Mahjoub Y
    Anaesth Crit Care Pain Med; 2015 Jun; 34(3):141-4. PubMed ID: 26004874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aztreonam in the treatment of urinary tract infections: a multicenter trial.
    Martelli A; Cortecchia V; Ventriglia L
    Chemotherapy; 1989; 35 Suppl 1():8-14. PubMed ID: 2659294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy of systemic murine infection due to beta-lactam antibiotic 'tolerant' and non-'tolerant' Staphylococcus aureus.
    Traub WH
    Chemotherapy; 1985; 31(1):40-9. PubMed ID: 3971778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aztreonam in the management of gram-negative infections in penicillin-allergic patients: a review.
    Saxon A
    Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S124-7; discussion S128-32. PubMed ID: 2682512
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
    Raad II; Whimbey EE; Rolston KV; Abi-Said D; Hachem RY; Pandya RG; Ghaddar HM; Karl CL; Bodey GP
    Cancer; 1996 Apr; 77(7):1386-94. PubMed ID: 8608520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Aztreonam treatment of severe infections caused by gram-negative aerobic bacilli].
    Peter JD; Jehl F; Froehly S; Dupeyron JP; Monteil H; Rosset MA
    Pathol Biol (Paris); 1988 May; 36(5):525-30. PubMed ID: 3043352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aztreonam in the treatment of serious gram-negative infections in the elderly.
    Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
    Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections.
    Felisart J; Rimola A; Arroyo V; Perez-Ayuso RM; Quintero E; Gines P; Rodes J
    Hepatology; 1985; 5(3):457-62. PubMed ID: 3888810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.